The ABOGRAFT trial is a multi-center randomized controlled double-blinded drug trial to investigate the effects of providing local antibiotics to prevent joint infection in patients who undergo hip replacement surgery using bone graft.
To reduce the number of patients that suffer from prosthetic joint infection after hip replacement.
This is a multi-center international randomized and double-blinded study. Patients are randomized into two groups:
- the treatment group will receive antibiotic impregnated bone graft
- the control group will receive a placebo.
The study protocol will be submitted to BMJ Open. If, in the meantime you would like to have access to the full protocol, send us an email.
Contact us: firstname.lastname@example.org
Get involved: Does your centre want to join the ABOGRAFT consortium? Contact us!